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Firing of action potentials in excitable cells accelerates ATP turn-
over. The voltage-gated potassium channel Kv2.1 regulates action
potential frequency in central neurons, whereas the ubiquitous
cellular energy sensor AMP-activated protein kinase (AMPK) is
activated by ATP depletion and protects cells by switching off
energy-consuming processes. We show that treatment of HEK293
cells expressing Kv2.1 with the AMPK activator A-769662 caused
hyperpolarizing shifts in the current–voltage relationship for chan-
nel activation and inactivation. We identiﬁed two sites (S440 and
S537) directly phosphorylated on Kv2.1 by AMPK and, using phos-
phospeciﬁc antibodies and quantitative mass spectrometry, show
that phosphorylation of both sites increased in A-769662–treated
cells. Effects of A-769662 were abolished in cells expressing Kv2.1
with S440A but not with S537A substitutions, suggesting that
phosphorylation of S440 was responsible for these effects. Identi-
cal shifts in voltage gating were observed after introducing into
cells, via the patch pipette, recombinant AMPK rendered active but
phosphatase-resistant by thiophosphorylation. Ionomycin caused
changes in Kv2.1 gating very similar to those caused by A-769662
but acted via a different mechanism involving Kv2.1 dephosphor-
ylation. In cultured rat hippocampal neurons, A-769662 caused
hyperpolarizing shifts in voltage gating similar to those in
HEK293 cells, effects that were abolished by intracellular dialysis
with Kv2.1 antibodies. When active thiophosphorylated AMPK
was introduced into cultured neurons via the patch pipette, a pro-
gressive, time-dependent decrease in the frequency of evoked ac-
tion potentials was observed. Our results suggest that activation
of AMPK in neurons during conditions of metabolic stress exerts
a protective role by reducing neuronal excitability and thus con-
serving energy.
calcineurin | calcium signaling | energy homeostasis
AMP-activated protein kinase (AMPK) is a ubiquitouslyexpressed sensor of cellular energy status (1). It is activated
in response to increases in cellular AMP:ATP and ADP:ATP
ratios by a mechanism involving allosteric activation and in-
creased net phosphorylation at a conserved threonine (Thr172)
mediated by the tumor-suppressor kinase, LKB1 (2). Thr172
phosphorylation and activation also can be triggered by increases
in cytoplasmic Ca2+ via the calmodulin-dependent kinase cal-
cium/calmodulin kinase kinase β (CaMKKβ) (1, 2). Although
AMPK initially was thought to maintain cellular energy ho-
meostasis primarily by regulating metabolism, emerging evidence
suggests that it also modulates cell function by phosphorylating
other targets, including ion channels. This function may be of
particular signiﬁcance in excitable cells such as central neurons.
Remarkably, ATP turnover in rodent brain is comparable with
that in human leg muscle during marathon running, and it has
been estimated that action potentials account for 25–50% of this
turnover, with synaptic transmission (triggered by action poten-
tials) accounting for all but 15% of the remainder (3, 4). Voltage-
gated K+ (Kv) channels are crucial determinants of membrane
excitability (5), and a major component of the delayed rectiﬁer
Kv current in cortical and hippocampal pyramidal neurons, es-
pecially in the somatodendritic region where they regulate ﬁring
of axonal action potentials, is provided by Kv2.1 (6). Changes in
the level of phosphorylation within the cytoplasmic C-terminal
tail of Kv2.1 have been proposed to underpin changes in its
gating properties and thereby neuronal activity, especially during
periods of metabolic stress such as hypoxia or ischemia (7, 8). We
therefore investigated the possibility that AMPK might modulate
neuronal excitability by direct phosphorylation and regulation
of Kv2.1.
Results
AMPK Activation Causes Shifts in Voltage Dependence of Kv2.1
Gating. HEK293 cells stably expressing rat Kv2.1 (8) were trea-
ted with the AMPK activator A-769662 (9, 10), which caused
maximal phosphorylation of acetyl-CoA carboxylase (ACC), a
marker for AMPK activation, at 200 μM within 10 min (Fig. S1).
Under these conditions A-769662 caused pronounced hyper-
polarizing shifts in the current–voltage relationship for Kv2.1
activation and inactivation (Fig. 1A), with half-maximal steady-
state activation (G0.5) shifting from +15 ± 1.7 to −15 ± 1.9 mV
(mean ± SEM), and half-maximal steady-state inactivation (Vi0.5)
shifting from −30 ± 0.9 to −52 ± 0.7 mV. These effects were
abolished by preincubation with compound C. Although it is not
a fully selective inhibitor of AMPK (11), reversal of the effects by
compound C supports the view that A-769662 modiﬁes Kv2.1
function by activating AMPK. It also was notable that the shifts
in steady-state activation and inactivation were accompanied by
increases in the rates of activation and inactivation (Fig. S2).
These initial observations supported our hypothesis that AMPK
reduces neuronal excitability by modulating Kv2.1 function.
AMPK Phosphorylates Kv2.1 at S440 and S537. To examine whether
AMPK directly phosphorylates Kv2.1, we immunoprecipitated
Kv2.1 from the HEK293 cells, treated with recombinant protein
phosphatase (PP1γ) and then incubated with or without puriﬁed
AMPK and [γ-32P]ATP. We observed AMPK-dependent phos-
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phorylation of a polypeptide migrating with the expected mass of
95 kDa recovered using anti-Kv2.1 but not control Ig (Fig. 1B).
The estimated stoichiometry of phosphorylation was 1.8 moles
per mole of Kv2.1, indicating more than one site of phosphory-
lation. To identify sites, we digested with trypsin and carried out
liquid chromatography-tandem MS (LC-MS:MS). We identiﬁed
six unique phosphorylated residues (S440/S443/S453/S480/S645/
S651) and eight phosphopeptides for which the exact site could
not be identiﬁed because of multiple S/T residues. All lie within
the C-terminal cytoplasmic domain (Fig. S3). Although multiple
Kv2.1 phosphorylation sites have been identiﬁed previously [15,
including S453, S480, and S651, in an analysis of rat Kv2.1 (8)
and 11, including S440, S480, and S651, in an analysis of the
mouse brain phosphoproteome (12)], the large number of sites
found was surprising, given that we had pretreated with PP1γ
before incubation with AMPK. However, this mass spectromet-
ric methodology is not quantitative and also cannot distinguish
between phosphate groups incompletely removed by PP1γ and
those introduced by AMPK. Of the sites identiﬁed, only S440 and
S537 are good ﬁts to the established AMPK recognition motif
(Fig. 1C). Both have basic residues at P−6 and P−4 and/or P−3,
plus hydrophobic residues at P−5 and P+4, key determinants for
AMPK recognition (13, 14) (although for S440 the hydrophobic
residue at P−5 is alanine, whereas a bulkier residue is preferred).
We obtained phosphospeciﬁc antibodies against S453 and
three other sites previously identiﬁed (S563/S603/S715) (8) and
made phosphospeciﬁc antibodies against S440 and S537. Kv2.1
immunoprecipitated from untreated cells yielded signals with
all six antibodies (Fig. 2A). As expected, all these signals were
eliminated by PP1γ treatment, which also caused a marked in-
crease in electrophoretic mobility of Kv2.1, consistent with de-
phosphorylation, as observed previously (7). After subsequent
phosphorylation by AMPK, a small decrease in electrophoretic
mobility was detected, but only signals obtained using pS440 and
pS537 antibodies were restored (Fig. 2A). This result conﬁrms
that S440 and S537, but not S453, S563, S603, or S715, are
phosphorylated by AMPK in cell-free assays. That S440 and
S537 represent the major AMPK sites was conﬁrmed when we
made isogenic HEK293 cells stably expressing WT, S440A,
S537A, or S440A/S537A substitutions of rat Kv2.1. The proteins
were immunoprecipitated, treated with PP1γ, and incubated with
or without AMPK and [γ-32P]ATP, as before. As expected, single
S440A or S537A substitutions reduced 32P-labeling of Kv2.1 by
AMPK, and a double substitution reduced it even further (Fig. 2B).
Shifts in Voltage Gating Caused by AMPK Require S440 Phosphor-
ylation. In cells expressing WT Kv2.1, A-769662 caused phos-
phorylation (Thr172) and activation of AMPK (shown by phos-
phorylation of ACC) that was maximal at 100–200 μM and 10–20
min. It also increased phosphorylation of Kv2.1 at S440 and S537
(Fig. 3 A and B) but not at S453, S563, S603, or S715 (Fig. S4).
Although the effects on S440/S537 phosphorylation were mod-
est, the signals obtained using either antibody were eliminated in
cells expressing the double substitution, conﬁrming antibody
speciﬁcity (Fig. 3C). We next assessed the effect of A-769662 on
Kv2.1 phosphorylation more quantitatively using stable isotope
labeling in culture (SILAC) using 13C/15N-labeled lysine/argi-
nine. We identiﬁed 17 phosphorylation sites (Table S1), all ex-
cept four of which had been identiﬁed previously (Fig. S3) (8).
However, only three showed heavy:light (H:L) ratios >1.2, in-
dicating increased phosphorylation in response to A-769662. The
sites with the highest ratios were S440 (1.3-fold) and S537 (1.4-
fold). In a repeat analysis, the H:L ratios for pS440 and pS537
were similar (1.3- and 1.5-fold, respectively).
Next, we analyzed the effects of A-769662 on the gating
properties of Kv2.1 in the isogenic cell lines expressing each of
Fig. 1. Effects of A-769662 on Kv2.1 function in HEK293 cells and phos-
phorylation of Kv2.1 by AMPK in cell-free assays. (A) HEK293 cells stably
expressing rat Kv2.1 (8) were incubated with A-769662 (100 μM) ± com-
pound C (40 μM) for 20 min. Activation is indicated by ﬁlled symbols and
continuous lines; inactivation is indicated by open symbols and dashed lines.
Data points are mean ± SEM (n = 5–15). Curves were obtained by ﬁtting to
the sigmoidal Boltzmann equation. (B) Phosphorylation of Kv2.1 by AMPK in
cell-free assays. Proteins were immunoprecipitated from HEK293 cells stably
expressing rat Kv2.1 using anti-Kv2.1 or control Ig (IgG), incubated with
[γ-32P]ATP ± puriﬁed AMPK, and SDS gels were analyzed by protein staining
(Upper) or autoradiography (Lower). (C) Alignment of the recognition motif
for AMPK with sequences around sites on ACC1, ACC2, HMG-CoA reductase
(HMGR), and Kv2.1. Basic and hydrophobic residues involved in recognition
by AMPK are marked by bold type and/or underlining.
Fig. 2. Evidence that S440 and S537 are the major AMPK sites on Kv2.1. (A)
Kv2.1 in immunoprecipitates made with anti-Kv2.1 (lanes 1–4) or control IgG
(lane 5) or in a cell lysate (lane 6) was probed using anti-Kv2.1 or Kv2.1
phosphospeciﬁc antibodies. In lane 2, the immunoprecipitates were treated
in a ﬁrst incubation with phosphatase (PP1γ), and in lanes 3 and 4 this in-
cubation was followed by a second incubation with ATP with or without
AMPK. (B) Kv2.1 immunoprecipitated from cells expressing WT or S440A/
S537A single or double mutants. Precipitates were treated with phosphatase
PP1γ and then with [γ-32P]ATP with or without AMPK.








the Kv2.1 variants (Fig. 4 and Table S2). In WT cells a marked
hyperpolarizing shift in steady-state activation, blocked by com-
pound C, was observed (Fig. 4A) as seen previously with the
independently generated WT cell line (Fig. 1A). This shift was
reduced greatly with the S440A substitution (Fig. 4B); a small
residual shift might appear to remain but was not statistically
signiﬁcant. For this mutant, effects on channel inactivation
mirrored effects on activation; the large shift in Vi0.5 (31 mV) in
response to A-769662 in the WT cells was lost. The S537A
substitution caused a small hyperpolarizing shift in activation
(relative to WT) in untreated cells [as observed previously (8)],
but a further shift of 18 mV in response to A-769662 (blocked by
compound C) was still evident. With the double mutant the
hyperpolarizing shift produced by A-769662 was abolished, but
the mutations alone had a large effect, so that the double mutant
had gating properties in untreated cells similar to those in WT
after A-769662 treatment.
We also analyzed the effect of AMPK on channel function by
applying, by intracellular dialysis via the patch pipette, bacterially
expressed human AMPK (α2β2γ1 complex) that had been acti-
vated by thiophosphorylation at Thr172 with CaMKKβ [thio-
phosphorylated AMPK is completely resistant to phosphatases
(15)] or an identically treated inactive mutant. In general, the
results were very similar to those obtained when A-769662 was
applied via the extracellular medium. The active AMPK (but not
the inactive control) caused a progressive time-dependent
hyperpolarizing shift in G0.5 that was half-maximal at 12 min and
maximal (33 mV) by 20 min (Fig. 4 E and F and Table S3).
Ionomycin Causes AMPK Activation and Shifts in Voltage Gating That
Do Not Involve S440 Phosphorylation. In HEK293 cells expressing
Kv2.1, the Ca2+ ionophore ionomycin induces a hyperpolarizing
shift in voltage gating very similar to that caused by A-769662
in this study. However, this shift was proposed to be caused by
dephosphorylation rather than by increased phosphorylation
(8). Because increases in Ca2+ also can activate AMPK by the
CaMKK pathway (1), we examined the effects of ionomycin on
the phosphorylation of Kv2.1. Ionomycin caused activation of
AMPK as assessed by increased phosphorylation of Thr172 on
AMPK and its downstream target ACC. Interestingly, this acti-
vation was not associated with signiﬁcant changes in phosphor-
ylation of S440 or S537 on Kv2.1 (Fig. S5A). There was, however,
a large dephosphorylation of S603, conﬁrming previous results
(8). We also analyzed ionomycin-induced changes in Kv2.1
phosphorylation by SILAC. This analysis revealed that seven
sites were dephosphorylated (H:L < 0.8; Table S4), three of
which (S11, S563, and S603) had been observed previously (8).
However, phosphorylation of S440 and S537 was unchanged (H:
L ∼ 1.00). We also tested the effects of ionomycin on voltage
gating in cells stably expressing Kv2.1, either WT cells or cells
with S440A or S440D substitutions (Fig. S5 and Table S5). The
cells with the S440D substitution, but not those with the S440A
substitution, exhibited a hyperpolarizing shift of 16 mV relative to
the WT cells, consistent with this substitution partially mimicking
phosphorylation at S440. Ionomycin caused substantial shifts in
gating in WT cells (20 mV) and in cells with the S440A sub-
stitution (21 mV) but not in cells with the S440D substitution.
AMPK Reduces Action Potential Frequency in Hippocampal Neurons.
To examine the relevance of our ﬁndings in a more physiological
setting, we examined the effect of A-769662 on K+ currents in
Fig. 3. Phosphorylation of ACC, AMPK, and Kv2.1 in response to A-769662
in isogenic HEK293 cells expressing Kv2.1 (duplicate cell incubations). (A)
Effect of A-769662 concentration. (B) Time course. (C) Phosphorylation of
S440/S537 in cells expressing either WT Kv2.1 or an S440A/S537A double
mutant. Panels labeled pACC, pAMPK, pS440, and pS537 are Western blots
obtained using appropriate phosphospeciﬁc antibodies.
Fig. 4. Voltage–conductance plots showing effects of AMPK on voltage
dependence of activation/inactivation in cells expressing WT or S440A/S537A
single/double substitutions. (A–D) Effects of preincubation in the bath with
A-769662 (100 μM, 20 min) ± compound C (40 μM). (E and F) Effect of in-
tracellular dialysis with thiophosphorylated active or inactive AMPK in-
troduced via the patch pipette. Individual data points are mean ± SEM (n =
7–10); results were ﬁtted to the sigmoidal Boltzmann equation, and the
curves were generated using the parameters shown in Table S2.
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cultured rat hippocampal neurons, measured after a prepulse to
inactivate transient K+ currents, thus isolating the delayed rec-
tiﬁer component. A-769662 caused a hyperpolarizing shift in
gating of 14 mV (Fig. 5A and Table S6), similar to results in
HEK293 cells expressing Kv2.1. After intracellular dialysis with
Kv2.1 antibody through the pipette, there was a reduction in
total current density (45 ± 7%, P < 0.01, n = 5), and the
remaining current yielded a G0.5 that was shifted in the hyper-
polarizing direction by 9 mV compared with that before dialysis.
However, there was no further shift in response to A-769662
(Fig. 5B), showing that the effect of A-769662 in untreated cells
was caused entirely by modulation of Kv2.1.
It has been proposed that hyperpolarizing shifts in Kv2.1
voltage gating would reduce the frequency of repetitive action
potential ﬁring from a given excitatory input (6). To determine
whether AMPK-dependent regulation of Kv2.1 might cause such
an effect, we introduced the active thiophosphorylated α2β2γ1
complex or inactive control into the cultured hippocampal neu-
rons via a patch pipette in whole-cell conﬁguration in the cur-
rent-clamp mode. Fig. 5 C and E show records of action
potentials induced by current pulses in the same cell before and
after intracellular dialysis (10 min); Fig. 5 D and F show results
with the inactive control. As predicted, active but not inactive
AMPK dramatically reduced the ﬁring frequency. Fig. 5G shows
plots of action potential frequency against time for several cells.
After a lag of 2–4 min, the frequency was reduced progressively
by intracellular dialysis of the active but not the inactive AMPK
complex. There also was a small but signiﬁcant hyperpolarization
of the resting membrane potential (11.6 ± 3.6%; P < 0.02) and
a small decrease in after-hyperpolarization amplitude (17.3 ±
6.6%; P < 0.05), but there were no signiﬁcant changes in the
duration, threshold, or amplitude of action potentials.
Discussion
Our results provide strong evidence that Kv2.1 is a direct target
for AMPK at S440 and S537 and that phosphorylation of S440
and S537 by AMPK is associated with hyperpolarizing shifts in
the voltage dependence of steady-state activation and inactiva-
tion of the channel. The S440A substitution abolished the effects
of AMPK activation on voltage gating, identifying this site as
being of primary importance for this effect. We suspect that
phosphorylation of S537 has other functions. One puzzling fea-
ture is that although the shifts in voltage gating were quite large,
the changes in phosphorylation of S440 were relatively small
(∼30%). Because Kv2.1 forms a homotetramer, one explanation
is that there is a high basal phosphorylation of S440, but all four
subunits must be phosphorylated to elicit an effect. A precedent
is provided by the regulation of the BKCa (KCa1.1) channel by
PKA, where phosphorylation of all four subunits of the homo-
tetramer at S899 is required for channel activation (16).
Another surprising feature of our results was that phosphor-
ylation of S440 by AMPK caused effects on Kv2.1 voltage gating
very similar to those caused by ionomycin, which previously was
shown to act by promoting dephosphorylation of Kv2.1 at mul-
tiple sites (8). Fig. S5A shows that ionomycin caused AMPK
activation [presumably via Ca2+/CaMKKβ-dependent phos-
phorylation of Thr-172, as in other cell types (17–19)]. However,
using either phosphospeciﬁc antibodies or SILAC, we found that
ionomycin did not change phosphorylation of S440 or S537, al-
though, using SILAC, we detected dephosphorylation of seven
other sites, including S563 and S603, as reported previously (8).
Moreover, a similar shift in voltage gating by ionomycin was
observed not only with WT Kv2.1 but also with an S440A mu-
tant. By contrast, the S440D mutant exhibited a signiﬁcant
hyperpolarizing shift relative to the WT and the S440A mutant,
although ionomycin had little further effect. These results con-
ﬁrm that the same change in voltage gating can be achieved via
parallel, complementary pathways involving increased phos-
phorylation at S440 by AMPK or decreased phosphorylation at
other sites (e.g., S563/S603) by calcineurin. The results with the
S440D mutant suggest that these effects might not be additive.
Fig. 5. Effect of AMPK on K+ conductance and action potentials in cultured
rat hippocampal neurons. (A) Voltage–conductance plot showing effects of
A-769662 on the isolated K+ delayed rectiﬁer current in native hippocampal
neurons. (B) Voltage–conductance plot for the K+ delayed rectiﬁer compo-
nent in hippocampal neurons before/after intracellular dialysis of Kv2.1
antibody (anti-Kv2.1) and after subsequent application of A-769662. In-
dividual data points are mean ± SEM (n = 5). Results were ﬁtted to the
sigmoidal Boltzmann equation, and the curves were generated using the
parameters shown in Table S6. (C–F) Sample recordings from two cells at
time 0 (C and D) and after intracellular dialysis for 10 min (E and F) of either
active (C and E) or inactive (D and F) AMPK. (G) Action potential frequency
(mean ± SEM of changes in individual cells over 10 min; n = 7; **P < 0.01;
***P < 0.001, Dunnett’s multiple comparison test). The mean initial fre-
quencies of the cells injected with the active and inactive heterotrimers were
47 ± 7 and 41 ± 7 Hz, respectively.








Another question is why ionomycin did not cause S440 and S537
phosphorylation even though it activated AMPK. One explana-
tion is that the pool of AMPK activated by A-769662 is in a
subcellular location different from that activated by ionomycin.
Interestingly, it has been shown (20) that AMPK activation using
2-deoxyglucose [which uses the classical AMP-dependent path-
way (21)] occurs exclusively in the cytoplasm, whereas activation
by Ca2+ ionophore also occurs in the nucleus.
Kv2.1 is expressed at high levels in the somatic and proximal
dendritic regions of central neurons, where it regulates the ini-
tiation of axonal action potentials (6). Because of the slow ki-
netics of Kv2.1 activation and inactivation, it has been argued
that hyperpolarizing shifts in voltage dependence would lead to
progressive Kv2.1 opening in response to repetitive action
potentials and would reduce the ﬁring frequency of axonal action
potentials (6). Indeed, glutamate suppresses the frequency of
action potentials in cultured rat hippocampal neurons in a man-
ner sensitive to the Kv2.1 inhibitor, hanatoxin (22). Our results
show that endogenous Kv2.1 in hippocampal neurons, in which
Kv2.1 contributes about half of the delayed rectiﬁer current, is
modulated by AMPK in the same manner as in HEK293 cells.
Moreover, the introduction of a homogeneous, phosphatase-re-
sistant AMPK via the patch pipette showed that AMPK reduces
the ﬁring of action potentials as predicted.
Our ﬁndings can be viewed as another illustration of the
function of AMPK in conserving energy, in this case serving to
protect central neurons against metabolic stress. AMPK-de-
pendent phosphorylation of Kv2.1 may provide, via a Ca2+-in-
dependent pathway, a mechanism complementary to that of
calcineurin-dependent dephosphorylation that enhances the
protection of neurons during periods of cerebral ischemia (7, 8).
It also has been shown recently that voltage gating of Kv2.1 is
modulated by SUMOylation (23).
Our results show that AMPK facilitates activation of a K+
channel and consequent inhibition of neuronal excitability via
direct phosphorylation at deﬁned sites. They demonstrate that
almost identical effects on Kv2.1 gating can be obtained by in-
creased phosphorylation at S440 or by decreased phosphoryla-
tion at other sites mediated by calcineurin. S563 and S603 are the
sites likely responsible for the latter effect, because both we and
Park, et al. (8) found these sites were dephosphorylated after
ionomycin administration, and a double S563A/S603A sub-
stitution caused a shift in gating almost as large as that induced
by ionomycin (8).
In contrast to the present results, AMPK has been reported to
phosphorylate and inactivate other K+ channels, including the
Ca2+-activated K+ channels KCa1.1 and KCa3.1 and the pore-
forming subunit of the KATP channel (Kir6.2) (24–27). Our
results suggest that AMPK can increase or decrease cell excit-
ability, determined by cell-speciﬁc expression of members of the
K+ channel superfamily. AMPK therefore offers great versatility
in its capacity to regulate metabolic status at the cellular and
whole body levels.
Materials and Methods
Sources of proteins, antibodies, and othermaterials andmethods used for cell
culture and immunoprecipitation of Kv2.1 from cell extracts are given in SI
Materials and Methods.
Tetracycline-Inducible Stable HEK293 Cell Line Expressing Rat Kv2.1. HEK293
host cells containing a single ﬂippase recognition target (FRT) site and also
independently incorporated pcDNA6/TR (Invitrogen) were transfected with
Polyfect (QIAGEN) using the plasmids pOG44 and pcDND5/FRT/TO/Kv2.1 at
a ratio of 9:1. Freshmediumwas added to the cells 24 h after transfection, and
medium containing 200 μg/mL hygromycin B was added 48 h after trans-
fection. The medium was replaced every 3 d until foci could be identiﬁed;
then individual foci were selected and expanded. The expression of Kv2.1
was checked using immunoﬂuorescence microscopy and Western blotting
using mouse anti-Kv2.1 α subunit antibodies (clone K89/34, NeuroMab).
In Vitro Phosphorylation of Kv2.1 by AMPK. Washed immunoprecipitates of
recombinant rat Kv2.1 from HEK293 cells were incubated with PP1γ for 20
min at 30 °C, followed by extensive washing with ice-cold lysis buffer and
then Hepes buffer [50 mM Na Hepes (pH 7.4), 1 mM DTT). The precipitate
was incubated with 5 mMMgCl2, 200 mM [γ-32P]ATP, 8 μM okadaic acid, with
or without AMPK puriﬁed from rat liver (28) (5 U/mL in the presence of 200
μM AMP; Fig. 1B) or bacterially expressed AMPK (α2β2γ1, 10 U/mL, previously
activated using CAMKKβ and ATP) (15) (Figs. 2–5) for 30 min at 30 °C. After
being washed ﬁve times with ice-cold Hepes buffer, the proteins were boiled
with lithium dodecyl sulfate sample buffer and subjected to Tris-acetate SDS
gel electrophoresis (Invitrogen). Incorporation of 32P was determined as
described previously (25). For the experiment shown in Fig. 1D, immuno-
precipitates were incubated with unlabeled ATP in place of [γ-32P]ATP and
were analyzed by Western blotting with anti-Kv2.1 or phosphospeciﬁc
antibodies as indicated.
Identiﬁcation of Phosphorylation Sites by LC-MS/MS. Lysate (2.8 mg) from
HEK293 cells expressing Kv2.1 was immunoprecipitated with 100 μg of Kv2.1
antibody and then incubated with PP1γ followed by phosphorylation by
AMPK as described above, except that [γ-32P]ATP was replaced by unlabeled
ATP. The gel was visualized by staining with Colloidal Blue (Invitrogen). The
excised gel band was analyzed as described previously (29).
SILAC. HEK293 cells were grown for >1 wk in Arg0-, Lys0-, or Arg6/Lys8-la-
beling DMEM (Dundee Cell Products) containing charcoal-ﬁltered FBS, 100 IU/
mL penicillin, 100 μg/mL streptomycin, and 200 μg/mL hygromycin B. Tetra-
cycline (100 ng/mL) was added 24 h before treatment. After treatment ±
200 μM A-769662 for 20 min, lysates were prepared as described above. The
labeled and unlabeled lysates were combined 1:1 according to protein con-
tent. The pooled lysates was preincubated with protein G-Sepharose for 1 h
at 4 °C followed by incubation with anti-Kv2.1 antibody and protein G-Sep-
harose overnight at 4 °C. The precipitates were subjected to Tris-acetate SDS gel
electrophoresis and visualized by Colloidal Blue staining. The sample was an-
alyzed as described above. Before application to the HPLC column, trypsin-
digested peptides were puriﬁed using a TiO2 column (30) to enrich phosphor-
ylated peptides. The raw data were analyzed with MaxQuant software.
Primary Culture of Hippocampal Neurons. Hippocampi from 6- to 8-d-old
Wistar rats were removed for mechanical and enzymatic dissociation. Tissue
was incubated for 15 min at 37 °C in PBS containing 0.25 μg/mL trypsin (EC
4.4.21.4, from bovine pancreas; Sigma). Trypsin digestion was terminated by
the addition of an equal volume of buffer containing 16 μg/mL soybean
trypsin inhibitor (SBTI, type I-S; Sigma), 0.5 μg/mL DNaseI (EC 3.1.21.1 type II
from bovine pancreas; 125 kU/mL; Sigma) and 1.5 mM MgSO4. Following
centrifugation at 1,400 × g for 5 min, cells were resuspended in minimal
Earle’s medium with 10% FCS, 19 mM KCl, 13 mM glucose, 50 IU/mL peni-
cillin, and 50 μg/mL streptomycin. One hundred microliters of cell suspension
was plated onto poly-L-lysine–coated coverslips (10-mm diameter) in a 24-
well plate for electrophysiology. Medium was replaced after 24 h with
medium containing 10% (vol/vol) horse serum in place of FCS and 80 μM
ﬂuorodeoxyuridine to prevent the proliferation of nonneuronal cells. After
48 h the medium was exchanged for one containing Neurobasal medium,
supplemented with 2% B-27, 1% penicillin/streptomycin, 0.5 mM L-gluta-
mine, and 25 μM L-glutamic acid. Cells were maintained in a humidiﬁed
incubator at 37 °C, 95% air/5% CO2 for 14 d, with medium replaced every
5–7 d. All experiments were performed with cells cultured for 5–14 d.
Electrophysiology. HEK293 cells. Fragments of coverslip with attached Kv2.1-
expressing HEK293 cells were transferred to a recording chamber, perfused at
3–5 mL/min [10 mM Na Hepes (pH 7.2), 140 mM NaCl, 5 mM KCl, 2 mM
MgCl2, 2 mM CaCl2, 10 mM glucose), and mounted on the stage of an
Olympus CK40 inverted microscope. K+ currents were recorded by whole-cell
patch clamp and evoked by a series of depolarizing steps from −90 to +80
mV in 10-mV increments for 500 ms. Recordings were at 37 °C unless oth-
erwise indicated. Patch pipettes had resistances of 4–6 MΩ. Series resistance
was monitored and compensated (60–80%) after achieving the whole-cell
conﬁguration. If a signiﬁcant (>20%) increase occurred during the re-
cording, the experiment was terminated. The pipette solution consisted of
10 mM Na Hepes (pH 7.2), 140 mM KCl, 5 mM EGTA, 2 mM MgCl2, 1 mM
CaCl2, and 10 mM, glucose. For some experiments a thiophosphorylated
AMPK complex (α2β2γ1, 2 U/mL) (15) was added to the pipette solution. The
control was identical except for a D157A mutation in α1 to render the kinase
inactive and was added at the same concentration. Conductance values (G)
were calculated from the equation G = I/(V − EK), where the Nernst equi-
librium potential EK was calculated as −89 mV at 37 °C. Normalized con-
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ductance/voltage proﬁles for the Kv2.1 channel were ﬁtted to a single
Boltzmann function with the form G = Gmax/(1 + exp[− (V − V1/2)/k]), where
Gmax is the maximal conductance, V1/2 is the test potential at which Kv2.1
channels have a half-maximal conductance (G0.5), and k represents the slope
of the activation curve. Signals were sampled at 10 kHz and low-pass ﬁltered
at 2 kHz. Voltage-clamp and analysis protocols were performed using an
Axopatch 200A ampliﬁer/Digidata 1200 interface controlled by Clampex 9.0
software (Molecular Devices). Off-line analysis was performed using
Clampﬁt 9.0 (Molecular Devices).
Hippocampal neurons. For voltage-clamp experiments, the protocol was similar
to that used for the HEK293 cells except for the inclusion of a single 30-ms
prepulse to −10 mV to inactivate transient K+ currents; the neurons also
were held at −70 mV. Signals were sampled at 10 kHz and low-pass ﬁltered
at 2 kHz. For some experiments, an anti-Kv2.1 antibody (Neuromab) was
added to the intracellular solution to give a ﬁnal concentration of 0.5 μg/mL
Action potential recordings were made in whole-cell current-clamp mode at
37 °C. Signals were low-pass ﬁltered at 1 kHz and sampled at 10 kHz. Action
potentials were evoked by 1-s current pulses (50–200 pA) at 0 and 10 min.
Additionally, action potentials were evoked every 2 min during the experi-
ments with a 100-pA current pulse. Patch electrodes (3–5 MΩ) contained
11 mM K Hepes (pH 7.2), 117 mM KCl, 10 mM NaCl, 11 mM EGTA, 2 mM
Na2ATP, 2 mM MgCl2, 1 mM CaCl2, and 0.3 mM NaGTP. Perfusate contained
117 mM NaCl, 4.5 mM KCl, 2.5 mM CaCl2, 1 mM MgCl2, 23 mM NaHCO3, and
11 mM glucose and was bubbled with mixed gas (95% air/5% CO2; pH 7.4).
In some experiments a thiophosphorylated AMPK complex (α2β2γ1) or
a D157A inactive control was added to the patch pipette at a concentration
of 2 U/mL or the equivalent concentration for the inactive mutant (15).
Action potential parameters were measured off-line from the ﬁrst action
potential generated in response to a 100-pA stimulus, using Clampﬁt 9.0
(Molecular Devices). Firing frequency was determined from the interspike
interval between the ﬁrst two action potentials.
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